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Abstract
The aim. The aim of the research was to study the influence of excipients amount on the technological parameters of the 
compression mixture and tablets based on dry extract of Origanum vulgare L. herb using the method of random balance.
Materials and methods. Objects of the study – Origanum vulgare L. herb dry extract, 8 excipients that have been studied at two 
quantitative levels. The tablets were prepared by direct compression method. The formulations were designed according to the method 
of random balance. The technological parameters of the compression mixture and tablets based on Origanum vulgare L. herb dry ex-
tract have been studied as a function of quantitative factors: silicon, magnesium carbonate basic, dioxide magnesium aluminometasili-
cate (Neusilin S1®), isomalt (GalenIQ™720), F-melt® Type C (co-spray dried excipients), sucralose, berry flavor and citric acid. 
Results and discussion. The increase in the amount of Neusilin S1®, GalenIQ™720 and F-melt®, and the decrease in the 
amount of magnesium carbonate basic and silicon dioxide improved the flowability expressed by the Hausner ratio. Results of bulk 
density and tapped density of the compression mixture depended on the quantities of GalenIQ™720 and F-melt®. All formulations 
of the prepared tablets had the rapid disintegration and ranging from 6 to 15 minutes. Resistance for crushing and friability tablets’ 
were improved with a decrease in the amount of silicon dioxide and increase in the amount of Neusilin S1®, F-melt® and sucralose. 
Higher resistance to moisture of tablets based on Origanum vulgare L. dry extract was obtained by using Neusilin S1®, F-melt® and 
sucralose on the upper levels.
Conclusions. The tablets based on Origanum vulgare L. herb dry extract were successfully manufactured by direct compres-
sion method. The random balance method enabled us to identify the most significant quantitative factors to optimize their composi-
tion in the tablets based on the dry extract of Origanum vulgare L. herb.
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1. Introduction
Seasonal influenza which is characterized by a fever, headache, dry cough, muscle and joint 
pain, feeling unwell, a runny nose and sore throat can cause severe illness or death especially in 
people at high risk. According to the WHO worldwide statistics, seasonal influenza annual epi-
demics result in about 3 to 5 million cases of severe illness, and about 290 000 to 650 000 respi-
ratory deaths [1]. An acute sore throat may be caused by an inflammatory process in the pharynx, 
tonsils or nasopharynx at the acute respiratory disease due a bacterial agent [2]. The local use of 
the tablets with antimicrobial substances has the direct influence on the viral and inflammatory 
agents, which can cause local pain relief, rapid pharmacological and prolonged action, and effec-
tiveness at the different types of sore throat that can help at the emotional problems associated with 
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a sore throat [3]. Origanum vulgare L. contains flavonoids, ascorbic acid, tannins, essential oil and 
has anti-inflammatory, wound-healing, hemostatic and antimicrobial properties [4–8]. We have 
developed technology of dry extract of this herb and have proved its antimicrobial activity and the 
anti-inflammatory effect [9]. According to results of analysis of the Ukrainian pharmaceutical 
market of medicines for the treatment of throat diseases the solid dosage forms are most commonly 
used dosage forms [10]. Thereof tablets based on Origanum vulgare L. herb dry extract are per-
spective for use in the treatment of the mucous membrane of the upper respiratory tract [11].
The aim of the research. The aim of our study was to analyze the influence of the amount 
of excipients on the technological parameters of compression mixture and tablets based on dry 
extract of Origanum Vulgare L. herb using the method of random balance.
In our study, we used the method of random balance, which is based on the fact that the 
significance of certain factor effects depends on their contribution to the response variance [12]. 
Primarily, the matrix of design of experiments was defined, the experiment took place and based 
on its results scatter diagrams were constructed. Significant factors are taken from scatter dia-
grams. The design construction of experiments matrix is preceded by coding the factors, selection 
of variation levels and by determining the experiment center [13].
2. Materials and methods
This research was performed in 2019–2020. The materials which we used for this study 
comprise a dry extract of Origanum Vulgare L. herb and excipients (silicon dioxide, magnesium 
carbonate basic, magnesium aluminometasilicate (Neusilin S2®), isomalt (GalenIQ™720), F-melt® 
Type C (co-spray dried excipients), sucralose, berry flavor and citric acid, microcrystalline cellu-
lose (MCC). Excipients were kindly provided by Witec Industrial.
The formulations were designed according to the method of random balance. In this design, 
technological parameters of tablets based on Oregano vulgare L. dry extract have been studied as 
a function of 8 quantitative factors. The names of factors, with their variation levels, are shown in 
the Table 1.
Table 1











х1 – mass of silicon dioxide in one tablet, g 0.005 0.020 0.015 0.010
х2 – mass of magnesium carbonate basic in one tablet, g 0.010 0.130 0.120 0.110
х3 – mass of Neusilin S1 in one tablet, g 0.010 0.030 0.020 0.010
х4 – mass of GalenIQ™720 in one tablet, g 0.010 0.130 0.120 0.110
х5 – mass of F-melt® C in one tablet, g 0.010 0.130 0.120 0.110
х6 – mass of sucralose in one tablet, g 0.0002 0.005 0.0048 0.0046
х7 – mass of berry flavor in one tablet, g 0.0005 0.005 0.0045 0.004
х8 – mass of citric acid in one tablet, g 0.005 0.015 0.010 0.005
Matrix 23 of full factorial experiment has been used to make random balance matrix. The 
design of matrix and obtained results (responses) are shown in the Table 2. The bulk density (у1), 
tapped density (у2), Hausner ratio (у3), friability of the tablets (у4), resistance of the tablet’s for 
crushing (у5), disintegration (у6) were evaluated.
Tablets based on Oregano vulgare L. dry extract have been obtained by direct compression 
method according to the matrix given in Table 2. All the ingredients were weighed and mixed to 
uniformity. Amount of Oregano vulgare L. dry extract in the one tablet was 0.125 g. MCC 200 was 
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added in the formulation to adjust tablets weight to 550 mg if factors were investigated at the lower 
levels. The compression mixture from each formula was evaluated by several parameters such as 
bulk density, tapped density, Hausner ratio. The mixtures were directly compressed using 12 mm 
semi-sphere round punches into tablets of 550 mg on a single tooling tablets machine. A batch 
of 50 tablets was prepared for all the designed formulations. Obtained tablets based on Oregano 
vulgare L. dry extract were evaluated for the following parameters: friability, resistance for crush-
ing, and disintegration of the tablets.
Table 2
Design of matrix of the tablets based on Oregano vulgare L. dry extract formulations and technological 
parameters of compression mixtures and obtained tablets
No.  
formula х1 х2 х3 х4 х5 х6 х7 х8













1 + + + + + + + + 0.382 0.423 1.107 0.016 47 15
2 – + + + – – – + 0.389 0.527 1.355 0.210 46 15
3 + – + + – – + – 0.360 0.517 1.434 1.800 30 9
4 – – + + + + – – 0.408 0.538 1.318 0.280 57 16
5 + + – + – – – – 0.366 0.441 1.203 1.550 23 9
6 – + – + + + + – 0.396 0.528 1.333 0.390 54 11
7 + – – + + + – + 0.372 0.542 1.454 0.800 32 10
8 – – – + – – + + 0.429 0.537 1.250 1.700 30 8
9 + + + – – + – – 0.340 0.432 1.272 1.550 37 9
10 – + + – + – + – 0.366 0.496 1.354 0.180 78 13
11 + – + – + – – + 0.344 0.485 1.408 0.660 52 10
12 – – + – – + + + 0.395 0.515 1.304 0.160 78 9
13 + + – – + – + + 0.337 0.472 1.400 1.170 27 8
14 – + – – – + – + 0.364 0.527 1.444 1.160 44 7
15 + – – – – + + – 0.345 0.486 1.408 0.150 43 11
16 – – – – + – – – 0.390 0.561 1.435 1.060 36 6
Bulk density of the compression mixture was determined by pouring the mixture into the 
graduated cylinder. The bulk volume and weight of the mixture were also determined. The bulk 
density is the ratio of the total mass of the compression mixture to the bulk volume [14].
Tapped density is the ratio of the total mass of the compression mixture and its tapped 
volume. The volume was measured by tapping the compression mixture 500 times [14]. Tapped 
volume was noted if the volume did not show a difference between two tapping intervals.
The compression mixture had not ability to flow that is why we could not determine flow-
ability using the funnel method. To express flowability we have used Hausner ratio. It expressed as 
the tapped density of the compression mixture divided by the bulk density [14].
The resistance of tablet’s for crushing is used to test the hardness of the tablets. The hard-
ness of each batch of tablets was measured in Newton, where five tablets from each formula were 
tested through Tablet’s hardness tester (Electrolab Company), and then the average value was do-
cumented [14].
The friability test was conducted by placing pre-weighed tablets in the Friability Tes-
ter (Electrolab Company); the latter was operated at 25 rpm for 4 min. The dust was removed 
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from the tablets surface and the tablets weight loss caused by fracture or abrasion was recor-
ded as the percentage weight loss. Tablets should lose not more than 1 % of their weight to be 
acceptable [14].
The disintegration test for all formulations was carried out using Disintegration Tes-
ters (Electrolab Company). Six tablets were placed individually in each tube of the disintegration 
test apparatus and discs were placed. The water was maintained at the temperature of 37 ± 2 °C 
and the time taken for the tablet disintegration was noted [14].
3. Results
According to the obtained results we have constructed scatter diagrams for each response in 
order to determinate the significant factors form these diagrams. The difference between the aver-
age values of the factor for the upper and lower levels determines the influence of the factor on the 
technological parameter of the compression mixture and obtained tablets. The difference between 
the average values of the parameter is shown through the median on scatter diagram. The value of 
the median indicates the significance of the factor.
The influence of quantitative factors on the bulk density of the compression mixture (y1) 
is depicted in Fig. 1.
Fig. 1. Scatter diagram of bulk density results
Based on the analysis of the scatter diagram of bulk density results we have defined the 
statistically significant effects of factors х1 and х4. The decrease in the amount of silicon di-
oxide causes the increase in the value of the bulk density and vise versa, the bigger content of 
GalenIQ™720 is introduced in the compression mixtures, the larger the value of bulk density 
becomes. According direction of the medians, higher amount of magnesium carbonate basic (fac-
tor x2) causes a reduction of the bulk density. Factors х3, х5, х6, x7 and х8 have a slight positive effect 
on the studied parameters.
The dependence of tapped density on quantitative factors is shown in the Fig. 2.
Factors x1, x2 x3 are statistical have been identified as statistically significant for studied 
parameter. The introduction of the silicon dioxide (factor x1) and magnesium carbonate basic (fac-
tor x2) at the lower level into the composition of the compression mixtures increase the value of 
the tapped density. 
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Fig. 2. Scatter diagram of tapped density results
Fig. 3. Scatter diagram of Hausner ratio results
The increase in the amount of silicon dioxide (х1) and citric acid (х8) cause the increase in 
the value of the Hauster ratio. This means that the flowability of the compression mixture becomes 
worse. At the upper level the factors x2, x3, x4, х6, and х7 value of the Hausner ratio decreases and 
flowability gets better.
The influence of the investigated factors on the friability of the tablets based on the Oregano 
vulgare L. dry extract is shown in Fig. 4.
We have discovered the statistical significance of the factors х1, x3, х5, x6, and x7 for studied 
parameter of the tablets. Introduction of Neusilin S1, F-melt® C, sucralose, and berry flavor on the 
upper level in the tablets makes better the friability of the tablets. The decrease in the amount of 
silicon dioxide in the tablets enables to improve the studied parameter. The dependence of resis-
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Fig. 4. Scatter diagram of tablets friability results
Fig. 5. Scatter diagram of tablets resistance for crushing results
Based on the analysis of the scatter diagram we have defined the statistically significant ef-
fects of factors х1, and х3. The better results of resistance for crushing tablets based on the Oregano 
vulgare L. dry extract were obtained at the lower levels of silicon dioxide and berry flavor. Increase 
in the amount of Neusilin S1, F-melt® C, and sucralose in the tablets have improved the hardness 
of the tablets.
The dependence of disintegration tablets on quantitative factors is shown in the Fig. 6.
The influence of the quantitative factors on the disintegration tablets based on the Oregano 
vulgare L. dry extract allowed us to reveal the statistical significance of the factors х3 and х6. The 
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Fig. 6. Scatter diagram of disintegration tablets results
4. Discussion
We used excipients that are widely used in the development of the composition and techno-
logy of tablets [15–18], as well as new excipients.
Neusilin US 2 was used at the development of technology of tablets based on the extracts of 
goat’s rue herb, extracts of bilberry leaves and taurine by direct compression method. It improved 
the homogeneity of the mass, increased the resistance to crushing, reduced friability and slightly 
reduced the disintegration time of the tablets [15]. The influence of the amounts of Neusilin US 2 on 
the technological indicators of the quality of compression mixture and the tablets with round-leaved 
wintergreen extract was determined. According to results increase in the amount of Neusilin US 2 
improves Carr index of compression mixture, resistance to crushing, and friability of the tablets [16].
Neusilin of two brands, US 2 and UFL-2, have been studied as moisture regulators at the 
development of composition and technology of the tablets based on the Malva sylvestris L. and 
Plantago lanceolata L. dry extracts [17]. Neusilin US 2 has provided the best results. 
Neusilin® UFL2 has been studied to increase solubility of poorly soluble drugs in the com-
position of an amorphous drug composites preparation [19].
Corn Starch-Neusilin UFL2 conjugates improved powder flow properties and disintegration 
of domperidone tablets [20].
The comparative evaluation of GalenIQ 721, against known excipients such as Pharma-
tose M200 and Alfacel type 102 has been performed. The influence of these excipients on com-
patibility properties, disintegration time and flowability has been studied. GalenIQ 721 gave better 
results than Pharmatose M200 but it inferior of Alfacel 102. Scientists predicted that the GalenIQ 
721 characteristics, could be more stable to changes in composition and process conditions than 
those of Alfacel 102 [21].
Usage of F-melt have helped in solving formulation problems at the development of orally 
disintegrating dosage forms and improved flowability, compressibility, palatability, dissolution, 
disintegration, and dust generation [22].
In our research the increase of Neusilin S1 and sucralose amount makes better almost all 
investigated parameters but increase disintegration time of tablets. Hence, on the next stage of our 
research, we have decided to investigate more detailed the impact of these excipients on the main 
technological parameters of tablets based on the Oregano vulgare L. dry extract. To define the 
optimal quantity of GalenIQ™720 and F-melt® C in the composition of the investigated tablets 
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the studied parameters, but we have made decision to define the influence of their amount on the 
tablets quality more details in the narrower range because these substances are novel and very little 
information we have about their usage in the pharmaceutical technology.
The amount of berry flavor has been decided to stabilize at the upper level of 0.005 g in the 
one tablet. 
The increase of silicon dioxide and magnesium carbonate basic amount had negative influ-
ence on most investigated parameters; citric acid have been defined as statistically insignificant 
factor. Hence, on the next stage of our research, we have decided to not use these excipients at 
development composition of the tablets based on the Oregano vulgare L. dry extract.
Therefore, excipients such as Neusilin S1, GalenIQ™720, F-melt® C, and sucralose will be 
used to optimize the composition of the tablets based on the Oregano vulgare L. dry extract with 
anti-inflammatory and antimicrobial properties for use in the treatment of a sore throat.
Study limitations. The study did not investigate the influence of excipientsʼ amount on the 
dissolution of the tablets and wetting time.
Prospects for further research. Further research is aimed at optimization of the compo-
sition of excipients for the development tablets based on dry extract of Origanum Vulgare L. herb.
5. Conclusion
Tablets based on the Oregano vulgare L. dry extract were successfully obtained by direct 
compression method. 
1. Based on the random balance method it is established the most significant quantitative 
factors influenced on the technological parameters of compression mixture and tablets based on 
the Oregano vulgare L. dry extract.
2. Taking into account the results of technological research we made decision to decrease 
amount of excipients in the composition of the tablets.
3. Considering that excipients such as Neusilin S1, GalenIQ™720, F-melt® C, and sucralose 
improved most of the technological parameters of the compression mixture and tablets with dry 
extract of Origanum Vulgare L. herb, they were included to the next experimental stage to develop 
the composition and technology of the tablets based on the Oregano vulgare L. dry extract with 
anti-inflammatory and antimicrobial properties for use in the treatment of a sore throat.
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